Sio Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Sio Capital Management’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-90,291	Closed	-$1.07M	–	79
2022 Q1	$1.07M	Buy	90,291 +223	+0.2%	+$3.99K	0.36%	48
2021 Q4	$2.94M	Hold	90,068	–	–	0.89%	31
2021 Q3	$4.03M	Buy	90,068 +10,068	+13%	+$492K	1.28%	26
2021 Q2	$4.36M	Buy	+80,000	New	+$4.74M	1.08%	32
2020 Q4	–	Sell	-16,678	Closed	-$1.47M	–	109
2020 Q3	$1.47M	Sell	16,678 -10,612	-39%	-$1.21M	0.29%	68
2020 Q2	$2.91M	Sell	27,290 -19,563	-42%	-$1.76M	0.85%	42
2020 Q1	$2.78M	Buy	46,853 +2,000	+4%	+$136K	0.93%	30
2019 Q4	$3.1M	Buy	+44,853	New	+$2.72M	0.74%	33

Other funds holding SYRS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sio Capital Management's SYRS Position: Q2 2022 in Review

Sio Capital Management sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2022, closing a stake of 90,291 shares — an estimated $1.07M sold.

Sio Capital Management first reported a position in SYRS in Q4 2019 and held it in 8 quarters. The position peaked at $4.36M in Q2 2021. 67 funds tracked by Wall St. Rank hold SYRS as of Q2 2022.

Sio Capital Management reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Sio Capital Management sold 90,291 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $1.07M.
Sio Capital Management first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
Sio Capital Management's Syros Pharmaceuticals, Inc. Common Stock position peaked at $4.36M in Q2 2021.
67 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Sio Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.